AAP Updates RSV, COVID-19 Vaccine Recommendations
AAP recommendations expand second-season RSV protection criteria for children ages 8 to 19 months, alongside updated infant COVID-19 vaccination recommendations.
AAP recommendations expand second-season RSV protection criteria for children ages 8 to 19 months, alongside updated infant COVID-19 vaccination recommendations.
Certain agricultural practices and natural landscapes influence the incidence of fungal respiratory infections across California.
In kidney transplant recipients, early antiviral treatment with remdesivir reduced the risk of organ rejection and heart complications by nearly half for up to one year after diagnosis.
The American Academy of Pediatrics (AAP) issued updated recommendations for the prevention and control of influenza in children for the 2026-27 season, urging vaccination for all children aged 6 months and older.
Merck is seeking expand approval for its RSV drug Enflonsia to include children under age two through their second year of risk.
President Donald Trump signed an executive order on Monday that revises federal recommendations for the childhood vaccination schedule, according to multiple media reports including the AP.